Summary of ACELRX PHARMACEUTICALS INC

ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.

2013 Base Salaries

On February 5, 2013, the Board of Directors (the "Board") of AcelRx Pharmaceuticals, Inc. (the "Company") approved the 2013 base salaries (effective retroactively to January 1, 2013) for certain of the Company's named executive officers (as defined in Item 402(a)(3) of Regulation S-K promulgated by the Securities and Exchange Commission, the "NEOs") in the amounts set forth in the table below.

     Named Executive Officer                                2013 Base Salary
     Richard A. King, Chief Executive Officer               $         475,000
     James H. Welch, Chief Financial Officer                $         307,500
     Pamela P. Palmer, M.D., Ph.D., Chief Medical Officer   $         409,000
     Badri Dasu, Chief Engineering Officer                  $         301,500
     Lawrence G. Hamel, Chief Development Officer           $         301,000

Bonus Payments

On February 5, 2013, the Board approved bonus payments for 2012 performance for
certain of the NEOs in the amount set forth in the table below, in accordance
with the Company's established 2012 Cash Bonus Plan.



       Named Executive Officer                                 2012 Bonus
       Richard A. King, Chief Executive Officer               $    170,400
       James H. Welch, Chief Financial Officer                $     95,232
       Pamela P. Palmer, M.D., Ph.D., Chief Medical Officer   $    134,034
       Badri Dasu, Chief Engineering Officer                  $     95,160
       Lawrence G. Hamel, Chief Development Officer           $     93,964